DPY19L4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.24689147895651E-12 |
Normal-vs-Stage2 |
1.17840000002367E-06 |
Normal-vs-Stage3 |
1.44262379819793E-12 |
Normal-vs-Stage4 |
2.1316282072803E-14 |
Stage1-vs-Stage2 |
7.355000E-01 |
Stage1-vs-Stage3 |
1.081620E-01 |
Stage1-vs-Stage4 |
7.665700E-02 |
Stage2-vs-Stage3 |
2.025000E-01 |
Stage2-vs-Stage4 |
2.181600E-01 |
Stage3-vs-Stage4 |
8.795400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62492241884138E-12 |
Normal-vs-AfricanAmerican |
3.5527136788005E-15 |
Normal-vs-Asian |
7.598000E-02 |
Caucasian-vs-AfricanAmerican |
5.065600E-02 |
Caucasian-vs-Asian |
1.962620E-01 |
AfricanAmerican-vs-Asian |
6.355100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
1.83697501654478E-12 |
Male-vs-Female |
9.716800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.3639983000362E-11 |
Normal-vs-Age(41-60Yrs) |
1.63613567139009E-12 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
5.75119951662373E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.687560E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.696000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.188600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.306000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.524000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.597000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.156100E-04 |
Normal-vs-Grade 2 |
1.01130004370731E-09 |
Normal-vs-Grade 3 |
1.99840144432528E-15 |
Normal-vs-Grade 4 |
1.11022302462516E-16 |
Grade 1-vs-Grade 2 |
2.164200E-01 |
Grade 1-vs-Grade 3 |
3.579200E-03 |
Grade 1-vs-Grade 4 |
8.021100E-04 |
Grade 2-vs-Grade 3 |
4.224600E-03 |
Grade 2-vs-Grade 4 |
9.92029999999922E-05 |
Grade 3-vs-Grade 4 |
3.096100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.62254670704942E-12 |
Normal-vs-ccB subtype |
1.78790315885635E-12 |
ccA subtype-vs-ccB subtype |
6.508200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.39008812741304E-12 |
Normal-vs-N1 |
1.40839999995812E-06 |
N0-vs-N1 |
1.358210E-01 |
|
|